Cargando…

Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis

INTRODUCTION: Identification of tumor specific neoantigen (TSN) immunogenicity is crucial to develop peptide/mRNA based anti-tumoral vaccines and/or adoptive T-cell immunotherapies; thus, accurate in-silico classification/prioritization proves critical for cost-effective clinical applications. Sever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nibeyro, Guadalupe, Baronetto, Veronica, Folco, Juan I., Pastore, Pablo, Girotti, Maria Romina, Prato, Laura, Morón, Gabriel, Luján, Hugo D., Fernández, Elmer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411733/ https://www.ncbi.nlm.nih.gov/pubmed/37564650 http://dx.doi.org/10.3389/fimmu.2023.1094236

Ejemplares similares

Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
por: Mariuzza, Roy A., et al.
Publicado: (2023)

Determinants for Neoantigen Identification
por: Garcia-Garijo, Andrea, et al.
Publicado: (2019)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
por: Wu, Jingcheng, et al.
Publicado: (2019)

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023)

Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction
por: Diao, Kaixuan, et al.
Publicado: (2022)

The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma
por: Zhang, Yan, et al.
Publicado: (2019)

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023)

Molecular mechanism of phosphopeptide neoantigen immunogenicity
por: Patskovsky, Yury, et al.
Publicado: (2023)

The Neoantigen Landscape of Mycosis Fungoides
por: Sivanand, Arunima, et al.
Publicado: (2020)

Editorial: The Clinical Application of Neoantigens
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Cancer neoantigens and immunogenicity: mutation position matters
por: Capietto, Aude-Hélène, et al.
Publicado: (2020)

An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
por: Olsson, Niclas, et al.
Publicado: (2021)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018)

Computational Prediction and Validation of Tumor-Associated Neoantigens
por: Roudko, Vladimir, et al.
Publicado: (2020)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Editorial: Autoimmune Diabetes: Molecular Mechanisms and Neoantigens
por: Kent, Sally C., et al.
Publicado: (2022)

Neoantigens and NK Cells: “Trick or Treat” the Cancers?
por: Lv, Dan, et al.
Publicado: (2022)

Designing neoantigen cancer vaccines, trials, and outcomes
por: Biswas, Nupur, et al.
Publicado: (2023)

Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
por: Leng, Qibin, et al.
Publicado: (2020)

3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
por: Devlin, Jason, et al.
Publicado: (2019)

DeepNeo: a webserver for predicting immunogenic neoantigens
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
por: Patskovsky, Yury, et al.
Publicado: (2023)

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
por: Rubinsteyn, Alex, et al.
Publicado: (2018)

Improvement of Neoantigen Identification Through Convolution Neural Network
por: Hao, Qing, et al.
Publicado: (2021)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022)

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017)

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
por: Bräunlein, Eva, et al.
Publicado: (2017)

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
por: Mutis, Tuna, et al.
Publicado: (2020)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021)

Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3btfsc531agnsojuii2fnt013m